Page last updated: 2024-09-03

mci 154 and Disease Models, Animal

mci 154 has been researched along with Disease Models, Animal in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, LM; Yang, GM1
Abe, Y; Kitada, Y; Narimatsu, A1
Abe, Y; Ishibashi, A; Kawasumi, H; Kitada, Y1
Goto, T; Hashimoto, H; Hosono, M; Nunoki, K; Sato, Y; Satoh, K; Taira, N1

Other Studies

4 other study(ies) available for mci 154 and Disease Models, Animal

ArticleYear
[Effect of MCI-154 on calcium sensitivity of vascular smooth muscle and its mechanism in hemorrhagic shock in rats].
    Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue, 2005, Volume: 17, Issue:1

    Topics: Animals; Calcium; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Female; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Protein Kinase C; Pyridazines; Random Allocation; Rats; Rats, Wistar; rho-Associated Kinases; Vasodilator Agents

2005
Effect of a calcium-sensitizing positive inotropic agent MCI-154 and its combined use with enalapril on postischemic contractile dysfunction of dog hearts.
    Journal of cardiovascular pharmacology, 1995, Volume: 26, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium; Cardiotonic Agents; Coronary Circulation; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Enalapril; Female; Infusions, Intravenous; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Pyridazines

1995
MCI-154, a Ca2+ sensitizer, increases survival in cardiomyopathic hamsters.
    European journal of pharmacology, 1999, May-14, Volume: 372, Issue:2

    Topics: Animals; Calcium; Cardiomyopathies; Cardiotonic Agents; Cricetinae; Disease Models, Animal; Male; Mesocricetus; Pyridazines

1999
Improvement of pentobarbital-induced heart failure by MCI-154, a novel and potent cardiotonic agent, in the dog heart-lung preparation.
    Japanese journal of pharmacology, 1988, Volume: 47, Issue:2

    Topics: Animals; Atenolol; Blood Pressure; Cardiac Output; Cardiotonic Agents; Disease Models, Animal; Dogs; Female; Heart Failure; Heart Rate; In Vitro Techniques; Male; Pentobarbital; Pyridazines

1988